Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depression With Comorbid Anxiety Symptoms”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableLooking for participantsNCT07041073
What this trial is testing

EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial

Who this might be right for
Major Depression With Comorbid Anxiety SymptomsMajor Depressive Disorder (MDD)
Corporacion Parc Tauli 72
Post-approval studies (Phase 4)Study completedNCT00330174
What this trial is testing

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

Who this might be right for
Alcohol DependenceMajor DepressionSocial Anxiety Disorder+1 more
Medical University of South Carolina 90
Post-approval studies (Phase 4)UnknownNCT02294305
What this trial is testing

Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder

Who this might be right for
Social Anxiety DisorderMajor Depressive Disorder
The Medical Research Network 40
Testing effectiveness (Phase 2)Study completedNCT00451516
What this trial is testing

St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety

Who this might be right for
Depressive Disorder, MajorAnxiety Disorders
The University of Queensland 50
Testing effectiveness (Phase 2)Study completedNCT00521352
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Depression

Who this might be right for
Panic DisorderMajor Depressive Disorder
New York State Psychiatric Institute 25
Early research (Phase 1)Looking for participantsNCT07113665
What this trial is testing

Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder

Who this might be right for
Anorexia Nervosa (DSM-IV Revised Criteria)
Sunnybrook Health Sciences Centre 10
Post-approval studies (Phase 4)Study completedNCT04220996
What this trial is testing

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)

Who this might be right for
MDDAnxiety Disorders
H. Lundbeck A/S 100
Post-approval studies (Phase 4)Study completedNCT00229645
What this trial is testing

A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety

Who this might be right for
Major Depression With Comorbid Anxiety Symptoms
Dr Alexander McIntyre Inc. 60
Not applicableStudy completedNCT01971203
What this trial is testing

Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat

Who this might be right for
Major Depressive DisorderGeneralized Anxiety Disorder
Icahn School of Medicine at Mount Sinai 62
Post-approval studies (Phase 4)Ended earlyNCT00182533
What this trial is testing

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Who this might be right for
Phobia, SocialPanic DisorderAgoraphobia+3 more
Hamilton Health Sciences Corporation 170
Large-scale testing (Phase 3)Ended earlyNCT00868374
What this trial is testing

Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder

Who this might be right for
Major Depressive DisorderGeneralized Anxiety Disorder
Keming Gao 23
Testing effectiveness (Phase 2)Looking for participantsNCT07115329
What this trial is testing

GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia

Who this might be right for
Major Depressive Disorder
Syndeio Biosciences, Inc 164